Efficacy and tolerability of currently available therapies for the mycosis fungoides and Sezary syndrome variants of cutaneous T-cell lymphoma
- 30 April 2007
- journal article
- review article
- Published by Elsevier BV in Cancer Treatment Reviews
- Vol. 33 (2), 146-160
- https://doi.org/10.1016/j.ctrv.2006.08.006
Abstract
No abstract availableKeywords
This publication has 129 references indexed in Scilit:
- Lack of Suppressive CD4+CD25+FOXP3+ T Cells in Advanced Stages of Primary Cutaneous T-Cell LymphomaJournal of Investigative Dermatology, 2006
- A modified staging classification for cutaneous T-cell lymphomaJournal of the American Academy of Dermatology, 2001
- Pentostatin (2′-deoxycoformycin) in the treatment of cutaneous T-cell lymphomaJournal of the American Academy of Dermatology, 1997
- Additional courses of total skin electron beam therapy in the treatment of patients with recurrent cutaneous T-cell lymphomaJournal of the American Academy of Dermatology, 1996
- Treatment of mycosis fungoides with photochemotherapy (PUVA): Long-term follow-upJournal of the American Academy of Dermatology, 1995
- Extracorporeal photopheresis for the treatment of cutaneous T-cell lymphomaJournal of the American Academy of Dermatology, 1992
- Treatment of erythrodermic cutaneous T-cell lymphoma with extracorporeal photochemotherapyJournal of the American Academy of Dermatology, 1992
- Topical carmustine (BCNU) for cutaneous T cell lymphoma: A 15-year experience in 143 patientsJournal of the American Academy of Dermatology, 1990
- Long-term efficacy, curative potential, and carcinogenicity of topical mechlorethamine chemotherapy in cutaneous T cell lymphomaJournal of the American Academy of Dermatology, 1989
- Photochemotherapy for cutaneous T cell lymphoma: A follow-up studyJournal of the American Academy of Dermatology, 1984